CVS Health study is first to show improved medication adherence and health outcomes for generic statins

A study by researchers at CVS Health and Brigham and Women's Hospital published in the Annals of Internal Medicine, is the first to investigate whether starting on a generic versus a brand-name drug for the treatment of high cholesterol is associated with improved health outcomes. The analysis found that patients who took a generic statin were more likely to be adherent to their medication than those starting on a branded drug, and had an eight percent lower rate of the composite endpoint of cardiovascular events and death.
The main outcome measures of the study were adherence to statin therapy and health outcomes as determined by tracking hospitalizations (CVS Website, 15 September 2014).
Click here for the full press release.
Click here for more information about the scientific article.

This item is also included in our monthly overview, the NVC Members-only Update. If you have any questions, please contact us: info@nvc.nl, +31-(0)182-512411.